一心堂: 关于全资子公司贵州鸿翔一心堂医药连锁有限公司对外投资取得土地使用权及其地上附着物的进展公告

Core Viewpoint - Yixin Pharmaceutical Group Co., Ltd. has approved an investment by its wholly-owned subsidiary, Guizhou Hongxiang Yixintang Pharmaceutical Chain Co., Ltd., to acquire land use rights and associated structures for a total investment of RMB 32.8 million [2]. Group 1: Investment Details - The investment involves acquiring land use rights and buildings located at No. 13, Longdongbao Food Industrial Park, Nanning District, Guiyang City, which has a building area of 17,521.25 square meters [2]. - The total area of the land parcel is 26,122.49 square meters, designated for industrial use [2][4]. - The land use rights are granted for a period starting from January 15, 2014, to January 15, 2064 [4]. Group 2: Legal and Administrative Aspects - The land use rights have been officially registered, and the company has obtained the "People's Republic of China Real Estate Property Certificate" for the property [2]. - The rights are classified as state-owned construction land use rights with a transfer nature [2].